nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—UGT1A9—Sorafenib—thyroid cancer	0.148	0.2	CbGbCtD
Buprenorphine—ABCG2—Vandetanib—thyroid cancer	0.111	0.149	CbGbCtD
Buprenorphine—ABCG2—Sorafenib—thyroid cancer	0.0667	0.09	CbGbCtD
Buprenorphine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0492	0.0665	CbGbCtD
Buprenorphine—CYP3A7—Sorafenib—thyroid cancer	0.0492	0.0665	CbGbCtD
Buprenorphine—ABCG2—Doxorubicin—thyroid cancer	0.0404	0.0546	CbGbCtD
Buprenorphine—CYP3A5—Sorafenib—thyroid cancer	0.0369	0.0498	CbGbCtD
Buprenorphine—CYP2C8—Sorafenib—thyroid cancer	0.0355	0.0479	CbGbCtD
Buprenorphine—CYP2C19—Sorafenib—thyroid cancer	0.0298	0.0402	CbGbCtD
Buprenorphine—CYP1A2—Sorafenib—thyroid cancer	0.0275	0.0371	CbGbCtD
Buprenorphine—CYP2C9—Sorafenib—thyroid cancer	0.0248	0.0334	CbGbCtD
Buprenorphine—ABCB1—Sorafenib—thyroid cancer	0.024	0.0324	CbGbCtD
Buprenorphine—CYP3A4—Vandetanib—thyroid cancer	0.0239	0.0322	CbGbCtD
Buprenorphine—CYP2D6—Sorafenib—thyroid cancer	0.0226	0.0306	CbGbCtD
Buprenorphine—ABCB1—Doxorubicin—thyroid cancer	0.0146	0.0197	CbGbCtD
Buprenorphine—CYP3A4—Sorafenib—thyroid cancer	0.0144	0.0194	CbGbCtD
Buprenorphine—CYP2D6—Doxorubicin—thyroid cancer	0.0137	0.0185	CbGbCtD
Buprenorphine—CYP3A4—Doxorubicin—thyroid cancer	0.00874	0.0118	CbGbCtD
Buprenorphine—Dyspepsia—Sorafenib—thyroid cancer	0.000424	0.00201	CcSEcCtD
Buprenorphine—Coma—Doxorubicin—thyroid cancer	0.000422	0.002	CcSEcCtD
Buprenorphine—Decreased appetite—Sorafenib—thyroid cancer	0.000419	0.00199	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000416	0.00197	CcSEcCtD
Buprenorphine—Fatigue—Sorafenib—thyroid cancer	0.000415	0.00197	CcSEcCtD
Buprenorphine—Pain—Sorafenib—thyroid cancer	0.000412	0.00195	CcSEcCtD
Buprenorphine—Constipation—Sorafenib—thyroid cancer	0.000412	0.00195	CcSEcCtD
Buprenorphine—Mental disability—Doxorubicin—thyroid cancer	0.000401	0.0019	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000394	0.00187	CcSEcCtD
Buprenorphine—Hot flush—Epirubicin—thyroid cancer	0.000387	0.00184	CcSEcCtD
Buprenorphine—Menopausal symptoms—Epirubicin—thyroid cancer	0.000384	0.00182	CcSEcCtD
Buprenorphine—Urticaria—Sorafenib—thyroid cancer	0.000383	0.00181	CcSEcCtD
Buprenorphine—Body temperature increased—Sorafenib—thyroid cancer	0.000381	0.00181	CcSEcCtD
Buprenorphine—Abdominal pain—Sorafenib—thyroid cancer	0.000381	0.00181	CcSEcCtD
Buprenorphine—Lethargy—Epirubicin—thyroid cancer	0.00037	0.00175	CcSEcCtD
Buprenorphine—Pain in extremity—Epirubicin—thyroid cancer	0.000362	0.00172	CcSEcCtD
Buprenorphine—Diplopia—Epirubicin—thyroid cancer	0.000362	0.00172	CcSEcCtD
Buprenorphine—Osteoarthritis—Epirubicin—thyroid cancer	0.000362	0.00172	CcSEcCtD
Buprenorphine—Hot flush—Doxorubicin—thyroid cancer	0.000358	0.0017	CcSEcCtD
Buprenorphine—Migraine—Epirubicin—thyroid cancer	0.000356	0.00169	CcSEcCtD
Buprenorphine—Affect lability—Epirubicin—thyroid cancer	0.000356	0.00169	CcSEcCtD
Buprenorphine—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000355	0.00168	CcSEcCtD
Buprenorphine—Hypersensitivity—Sorafenib—thyroid cancer	0.000355	0.00168	CcSEcCtD
Buprenorphine—Face oedema—Epirubicin—thyroid cancer	0.00035	0.00166	CcSEcCtD
Buprenorphine—Asthenia—Sorafenib—thyroid cancer	0.000346	0.00164	CcSEcCtD
Buprenorphine—Mood swings—Epirubicin—thyroid cancer	0.000343	0.00163	CcSEcCtD
Buprenorphine—Lethargy—Doxorubicin—thyroid cancer	0.000342	0.00162	CcSEcCtD
Buprenorphine—Pruritus—Sorafenib—thyroid cancer	0.000341	0.00162	CcSEcCtD
Buprenorphine—Dehydration—Epirubicin—thyroid cancer	0.000337	0.0016	CcSEcCtD
Buprenorphine—Diplopia—Doxorubicin—thyroid cancer	0.000335	0.00159	CcSEcCtD
Buprenorphine—Pain in extremity—Doxorubicin—thyroid cancer	0.000335	0.00159	CcSEcCtD
Buprenorphine—Osteoarthritis—Doxorubicin—thyroid cancer	0.000335	0.00159	CcSEcCtD
Buprenorphine—Dry skin—Epirubicin—thyroid cancer	0.000332	0.00157	CcSEcCtD
Buprenorphine—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000331	0.00157	CcSEcCtD
Buprenorphine—Abdominal pain upper—Epirubicin—thyroid cancer	0.000331	0.00157	CcSEcCtD
Buprenorphine—Migraine—Doxorubicin—thyroid cancer	0.00033	0.00156	CcSEcCtD
Buprenorphine—Affect lability—Doxorubicin—thyroid cancer	0.00033	0.00156	CcSEcCtD
Buprenorphine—Diarrhoea—Sorafenib—thyroid cancer	0.00033	0.00156	CcSEcCtD
Buprenorphine—Breast disorder—Epirubicin—thyroid cancer	0.000327	0.00155	CcSEcCtD
Buprenorphine—Nasopharyngitis—Epirubicin—thyroid cancer	0.000324	0.00154	CcSEcCtD
Buprenorphine—Face oedema—Doxorubicin—thyroid cancer	0.000323	0.00153	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000319	0.00152	CcSEcCtD
Buprenorphine—Muscular weakness—Epirubicin—thyroid cancer	0.000319	0.00152	CcSEcCtD
Buprenorphine—Dizziness—Sorafenib—thyroid cancer	0.000318	0.00151	CcSEcCtD
Buprenorphine—Mood swings—Doxorubicin—thyroid cancer	0.000317	0.00151	CcSEcCtD
Buprenorphine—Abdominal distension—Epirubicin—thyroid cancer	0.000315	0.00149	CcSEcCtD
Buprenorphine—Dysphagia—Epirubicin—thyroid cancer	0.000313	0.00148	CcSEcCtD
Buprenorphine—Asthma—Epirubicin—thyroid cancer	0.000313	0.00148	CcSEcCtD
Buprenorphine—Influenza—Epirubicin—thyroid cancer	0.000313	0.00148	CcSEcCtD
Buprenorphine—Dehydration—Doxorubicin—thyroid cancer	0.000312	0.00148	CcSEcCtD
Buprenorphine—Dry skin—Doxorubicin—thyroid cancer	0.000307	0.00146	CcSEcCtD
Buprenorphine—Vomiting—Sorafenib—thyroid cancer	0.000306	0.00145	CcSEcCtD
Buprenorphine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000306	0.00145	CcSEcCtD
Buprenorphine—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000306	0.00145	CcSEcCtD
Buprenorphine—Angina pectoris—Epirubicin—thyroid cancer	0.000305	0.00145	CcSEcCtD
Buprenorphine—Rash—Sorafenib—thyroid cancer	0.000304	0.00144	CcSEcCtD
Buprenorphine—Dermatitis—Sorafenib—thyroid cancer	0.000303	0.00144	CcSEcCtD
Buprenorphine—Breast disorder—Doxorubicin—thyroid cancer	0.000303	0.00144	CcSEcCtD
Buprenorphine—Headache—Sorafenib—thyroid cancer	0.000302	0.00143	CcSEcCtD
Buprenorphine—Bronchitis—Epirubicin—thyroid cancer	0.000301	0.00143	CcSEcCtD
Buprenorphine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.0003	0.00142	CcSEcCtD
Buprenorphine—Muscular weakness—Doxorubicin—thyroid cancer	0.000296	0.0014	CcSEcCtD
Buprenorphine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000296	0.0014	CcSEcCtD
Buprenorphine—Abdominal distension—Doxorubicin—thyroid cancer	0.000292	0.00138	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000291	0.00138	CcSEcCtD
Buprenorphine—Influenza—Doxorubicin—thyroid cancer	0.00029	0.00137	CcSEcCtD
Buprenorphine—Asthma—Doxorubicin—thyroid cancer	0.00029	0.00137	CcSEcCtD
Buprenorphine—Dysphagia—Doxorubicin—thyroid cancer	0.00029	0.00137	CcSEcCtD
Buprenorphine—Nausea—Sorafenib—thyroid cancer	0.000286	0.00136	CcSEcCtD
Buprenorphine—Weight decreased—Epirubicin—thyroid cancer	0.000283	0.00134	CcSEcCtD
Buprenorphine—Angina pectoris—Doxorubicin—thyroid cancer	0.000282	0.00134	CcSEcCtD
Buprenorphine—Infestation NOS—Epirubicin—thyroid cancer	0.000279	0.00132	CcSEcCtD
Buprenorphine—Infestation—Epirubicin—thyroid cancer	0.000279	0.00132	CcSEcCtD
Buprenorphine—Bronchitis—Doxorubicin—thyroid cancer	0.000279	0.00132	CcSEcCtD
Buprenorphine—Conjunctivitis—Epirubicin—thyroid cancer	0.000271	0.00129	CcSEcCtD
Buprenorphine—Urinary tract infection—Epirubicin—thyroid cancer	0.000271	0.00129	CcSEcCtD
Buprenorphine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000269	0.00128	CcSEcCtD
Buprenorphine—Sweating—Epirubicin—thyroid cancer	0.000268	0.00127	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000264	0.00125	CcSEcCtD
Buprenorphine—Weight decreased—Doxorubicin—thyroid cancer	0.000262	0.00124	CcSEcCtD
Buprenorphine—Sinusitis—Epirubicin—thyroid cancer	0.000262	0.00124	CcSEcCtD
Buprenorphine—Infestation NOS—Doxorubicin—thyroid cancer	0.000258	0.00122	CcSEcCtD
Buprenorphine—Infestation—Doxorubicin—thyroid cancer	0.000258	0.00122	CcSEcCtD
Buprenorphine—Bradycardia—Epirubicin—thyroid cancer	0.000255	0.00121	CcSEcCtD
Buprenorphine—Rhinitis—Epirubicin—thyroid cancer	0.000251	0.00119	CcSEcCtD
Buprenorphine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000251	0.00119	CcSEcCtD
Buprenorphine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000251	0.00119	CcSEcCtD
Buprenorphine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000249	0.00118	CcSEcCtD
Buprenorphine—Pharyngitis—Epirubicin—thyroid cancer	0.000249	0.00118	CcSEcCtD
Buprenorphine—Sweating—Doxorubicin—thyroid cancer	0.000248	0.00117	CcSEcCtD
Buprenorphine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000247	0.00117	CcSEcCtD
Buprenorphine—Oedema peripheral—Epirubicin—thyroid cancer	0.000247	0.00117	CcSEcCtD
Buprenorphine—Connective tissue disorder—Epirubicin—thyroid cancer	0.000246	0.00117	CcSEcCtD
Buprenorphine—Urethral disorder—Epirubicin—thyroid cancer	0.000246	0.00116	CcSEcCtD
Buprenorphine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000244	0.00116	CcSEcCtD
Buprenorphine—Sinusitis—Doxorubicin—thyroid cancer	0.000242	0.00115	CcSEcCtD
Buprenorphine—Visual impairment—Epirubicin—thyroid cancer	0.000241	0.00115	CcSEcCtD
Buprenorphine—Bradycardia—Doxorubicin—thyroid cancer	0.000236	0.00112	CcSEcCtD
Buprenorphine—Eye disorder—Epirubicin—thyroid cancer	0.000234	0.00111	CcSEcCtD
Buprenorphine—Tinnitus—Epirubicin—thyroid cancer	0.000234	0.00111	CcSEcCtD
Buprenorphine—Cardiac disorder—Epirubicin—thyroid cancer	0.000233	0.0011	CcSEcCtD
Buprenorphine—Flushing—Epirubicin—thyroid cancer	0.000233	0.0011	CcSEcCtD
Buprenorphine—Rhinitis—Doxorubicin—thyroid cancer	0.000232	0.0011	CcSEcCtD
Buprenorphine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000231	0.00109	CcSEcCtD
Buprenorphine—Pharyngitis—Doxorubicin—thyroid cancer	0.00023	0.00109	CcSEcCtD
Buprenorphine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000229	0.00109	CcSEcCtD
Buprenorphine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000228	0.00108	CcSEcCtD
Buprenorphine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000228	0.00108	CcSEcCtD
Buprenorphine—Angiopathy—Epirubicin—thyroid cancer	0.000227	0.00108	CcSEcCtD
Buprenorphine—Urethral disorder—Doxorubicin—thyroid cancer	0.000227	0.00108	CcSEcCtD
Buprenorphine—Immune system disorder—Epirubicin—thyroid cancer	0.000226	0.00107	CcSEcCtD
Buprenorphine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000226	0.00107	CcSEcCtD
Buprenorphine—Chills—Epirubicin—thyroid cancer	0.000225	0.00107	CcSEcCtD
Buprenorphine—Visual impairment—Doxorubicin—thyroid cancer	0.000223	0.00106	CcSEcCtD
Buprenorphine—Mental disorder—Epirubicin—thyroid cancer	0.000219	0.00104	CcSEcCtD
Buprenorphine—Erythema—Epirubicin—thyroid cancer	0.000218	0.00103	CcSEcCtD
Buprenorphine—Malnutrition—Epirubicin—thyroid cancer	0.000218	0.00103	CcSEcCtD
Buprenorphine—Eye disorder—Doxorubicin—thyroid cancer	0.000217	0.00103	CcSEcCtD
Buprenorphine—Tinnitus—Doxorubicin—thyroid cancer	0.000216	0.00103	CcSEcCtD
Buprenorphine—Flushing—Doxorubicin—thyroid cancer	0.000215	0.00102	CcSEcCtD
Buprenorphine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000215	0.00102	CcSEcCtD
Buprenorphine—Flatulence—Epirubicin—thyroid cancer	0.000215	0.00102	CcSEcCtD
Buprenorphine—Tension—Epirubicin—thyroid cancer	0.000214	0.00102	CcSEcCtD
Buprenorphine—Dysgeusia—Epirubicin—thyroid cancer	0.000214	0.00101	CcSEcCtD
Buprenorphine—Nervousness—Epirubicin—thyroid cancer	0.000212	0.001	CcSEcCtD
Buprenorphine—Back pain—Epirubicin—thyroid cancer	0.000211	0.001	CcSEcCtD
Buprenorphine—Angiopathy—Doxorubicin—thyroid cancer	0.00021	0.000998	CcSEcCtD
Buprenorphine—Muscle spasms—Epirubicin—thyroid cancer	0.00021	0.000995	CcSEcCtD
Buprenorphine—Immune system disorder—Doxorubicin—thyroid cancer	0.000209	0.000993	CcSEcCtD
Buprenorphine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000209	0.000991	CcSEcCtD
Buprenorphine—Chills—Doxorubicin—thyroid cancer	0.000208	0.000987	CcSEcCtD
Buprenorphine—Vision blurred—Epirubicin—thyroid cancer	0.000206	0.000975	CcSEcCtD
Buprenorphine—Mental disorder—Doxorubicin—thyroid cancer	0.000203	0.000963	CcSEcCtD
Buprenorphine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000202	0.00096	CcSEcCtD
Buprenorphine—Erythema—Doxorubicin—thyroid cancer	0.000202	0.000957	CcSEcCtD
Buprenorphine—Malnutrition—Doxorubicin—thyroid cancer	0.000202	0.000957	CcSEcCtD
Buprenorphine—Agitation—Epirubicin—thyroid cancer	0.0002	0.000951	CcSEcCtD
Buprenorphine—Flatulence—Doxorubicin—thyroid cancer	0.000199	0.000943	CcSEcCtD
Buprenorphine—Tension—Doxorubicin—thyroid cancer	0.000198	0.000939	CcSEcCtD
Buprenorphine—Dysgeusia—Doxorubicin—thyroid cancer	0.000198	0.000937	CcSEcCtD
Buprenorphine—Malaise—Epirubicin—thyroid cancer	0.000197	0.000933	CcSEcCtD
Buprenorphine—Nervousness—Doxorubicin—thyroid cancer	0.000196	0.00093	CcSEcCtD
Buprenorphine—Vertigo—Epirubicin—thyroid cancer	0.000196	0.000929	CcSEcCtD
Buprenorphine—Syncope—Epirubicin—thyroid cancer	0.000196	0.000928	CcSEcCtD
Buprenorphine—Back pain—Doxorubicin—thyroid cancer	0.000195	0.000926	CcSEcCtD
Buprenorphine—Muscle spasms—Doxorubicin—thyroid cancer	0.000194	0.00092	CcSEcCtD
Buprenorphine—Palpitations—Epirubicin—thyroid cancer	0.000193	0.000914	CcSEcCtD
Buprenorphine—Loss of consciousness—Epirubicin—thyroid cancer	0.000192	0.000909	CcSEcCtD
Buprenorphine—Cough—Epirubicin—thyroid cancer	0.00019	0.000903	CcSEcCtD
Buprenorphine—Vision blurred—Doxorubicin—thyroid cancer	0.00019	0.000902	CcSEcCtD
Buprenorphine—Convulsion—Epirubicin—thyroid cancer	0.000189	0.000896	CcSEcCtD
Buprenorphine—Hypertension—Epirubicin—thyroid cancer	0.000188	0.000893	CcSEcCtD
Buprenorphine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000187	0.000888	CcSEcCtD
Buprenorphine—Myalgia—Epirubicin—thyroid cancer	0.000186	0.000881	CcSEcCtD
Buprenorphine—Arthralgia—Epirubicin—thyroid cancer	0.000186	0.000881	CcSEcCtD
Buprenorphine—Chest pain—Epirubicin—thyroid cancer	0.000186	0.000881	CcSEcCtD
Buprenorphine—Agitation—Doxorubicin—thyroid cancer	0.000185	0.00088	CcSEcCtD
Buprenorphine—Anxiety—Epirubicin—thyroid cancer	0.000185	0.000878	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000184	0.000875	CcSEcCtD
Buprenorphine—Discomfort—Epirubicin—thyroid cancer	0.000183	0.00087	CcSEcCtD
Buprenorphine—Malaise—Doxorubicin—thyroid cancer	0.000182	0.000863	CcSEcCtD
Buprenorphine—Dry mouth—Epirubicin—thyroid cancer	0.000182	0.000861	CcSEcCtD
Buprenorphine—Vertigo—Doxorubicin—thyroid cancer	0.000181	0.00086	CcSEcCtD
Buprenorphine—Syncope—Doxorubicin—thyroid cancer	0.000181	0.000858	CcSEcCtD
Buprenorphine—Confusional state—Epirubicin—thyroid cancer	0.000179	0.000851	CcSEcCtD
Buprenorphine—Palpitations—Doxorubicin—thyroid cancer	0.000178	0.000846	CcSEcCtD
Buprenorphine—Oedema—Epirubicin—thyroid cancer	0.000178	0.000844	CcSEcCtD
Buprenorphine—Anaphylactic shock—Epirubicin—thyroid cancer	0.000178	0.000844	CcSEcCtD
Buprenorphine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000177	0.000841	CcSEcCtD
Buprenorphine—Infection—Epirubicin—thyroid cancer	0.000177	0.000839	CcSEcCtD
Buprenorphine—Cough—Doxorubicin—thyroid cancer	0.000176	0.000835	CcSEcCtD
Buprenorphine—Shock—Epirubicin—thyroid cancer	0.000175	0.000831	CcSEcCtD
Buprenorphine—Convulsion—Doxorubicin—thyroid cancer	0.000175	0.000829	CcSEcCtD
Buprenorphine—Nervous system disorder—Epirubicin—thyroid cancer	0.000175	0.000828	CcSEcCtD
Buprenorphine—Hypertension—Doxorubicin—thyroid cancer	0.000174	0.000826	CcSEcCtD
Buprenorphine—Tachycardia—Epirubicin—thyroid cancer	0.000174	0.000824	CcSEcCtD
Buprenorphine—Skin disorder—Epirubicin—thyroid cancer	0.000173	0.00082	CcSEcCtD
Buprenorphine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000172	0.000816	CcSEcCtD
Buprenorphine—Arthralgia—Doxorubicin—thyroid cancer	0.000172	0.000815	CcSEcCtD
Buprenorphine—Chest pain—Doxorubicin—thyroid cancer	0.000172	0.000815	CcSEcCtD
Buprenorphine—Myalgia—Doxorubicin—thyroid cancer	0.000172	0.000815	CcSEcCtD
Buprenorphine—Anxiety—Doxorubicin—thyroid cancer	0.000171	0.000812	CcSEcCtD
Buprenorphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000171	0.000809	CcSEcCtD
Buprenorphine—Discomfort—Doxorubicin—thyroid cancer	0.00017	0.000805	CcSEcCtD
Buprenorphine—Anorexia—Epirubicin—thyroid cancer	0.00017	0.000805	CcSEcCtD
Buprenorphine—Dry mouth—Doxorubicin—thyroid cancer	0.000168	0.000797	CcSEcCtD
Buprenorphine—Hypotension—Epirubicin—thyroid cancer	0.000166	0.000789	CcSEcCtD
Buprenorphine—Confusional state—Doxorubicin—thyroid cancer	0.000166	0.000788	CcSEcCtD
Buprenorphine—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000165	0.000781	CcSEcCtD
Buprenorphine—Oedema—Doxorubicin—thyroid cancer	0.000165	0.000781	CcSEcCtD
Buprenorphine—Infection—Doxorubicin—thyroid cancer	0.000164	0.000776	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000162	0.000769	CcSEcCtD
Buprenorphine—Shock—Doxorubicin—thyroid cancer	0.000162	0.000769	CcSEcCtD
Buprenorphine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000162	0.000766	CcSEcCtD
Buprenorphine—Insomnia—Epirubicin—thyroid cancer	0.000161	0.000764	CcSEcCtD
Buprenorphine—Tachycardia—Doxorubicin—thyroid cancer	0.000161	0.000762	CcSEcCtD
Buprenorphine—Skin disorder—Doxorubicin—thyroid cancer	0.00016	0.000759	CcSEcCtD
Buprenorphine—Paraesthesia—Epirubicin—thyroid cancer	0.00016	0.000758	CcSEcCtD
Buprenorphine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000159	0.000755	CcSEcCtD
Buprenorphine—Dyspnoea—Epirubicin—thyroid cancer	0.000159	0.000753	CcSEcCtD
Buprenorphine—Somnolence—Epirubicin—thyroid cancer	0.000158	0.000751	CcSEcCtD
Buprenorphine—Anorexia—Doxorubicin—thyroid cancer	0.000157	0.000745	CcSEcCtD
Buprenorphine—Dyspepsia—Epirubicin—thyroid cancer	0.000157	0.000743	CcSEcCtD
Buprenorphine—Decreased appetite—Epirubicin—thyroid cancer	0.000155	0.000734	CcSEcCtD
Buprenorphine—Hypotension—Doxorubicin—thyroid cancer	0.000154	0.00073	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000154	0.000729	CcSEcCtD
Buprenorphine—Fatigue—Epirubicin—thyroid cancer	0.000153	0.000728	CcSEcCtD
Buprenorphine—Constipation—Epirubicin—thyroid cancer	0.000152	0.000722	CcSEcCtD
Buprenorphine—Pain—Epirubicin—thyroid cancer	0.000152	0.000722	CcSEcCtD
Buprenorphine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00015	0.000712	CcSEcCtD
Buprenorphine—Insomnia—Doxorubicin—thyroid cancer	0.000149	0.000707	CcSEcCtD
Buprenorphine—Paraesthesia—Doxorubicin—thyroid cancer	0.000148	0.000701	CcSEcCtD
Buprenorphine—Dyspnoea—Doxorubicin—thyroid cancer	0.000147	0.000696	CcSEcCtD
Buprenorphine—Feeling abnormal—Epirubicin—thyroid cancer	0.000147	0.000696	CcSEcCtD
Buprenorphine—Somnolence—Doxorubicin—thyroid cancer	0.000146	0.000694	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000146	0.00069	CcSEcCtD
Buprenorphine—Dyspepsia—Doxorubicin—thyroid cancer	0.000145	0.000688	CcSEcCtD
Buprenorphine—Decreased appetite—Doxorubicin—thyroid cancer	0.000143	0.000679	CcSEcCtD
Buprenorphine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000142	0.000674	CcSEcCtD
Buprenorphine—Fatigue—Doxorubicin—thyroid cancer	0.000142	0.000674	CcSEcCtD
Buprenorphine—Urticaria—Epirubicin—thyroid cancer	0.000141	0.000671	CcSEcCtD
Buprenorphine—Constipation—Doxorubicin—thyroid cancer	0.000141	0.000668	CcSEcCtD
Buprenorphine—Pain—Doxorubicin—thyroid cancer	0.000141	0.000668	CcSEcCtD
Buprenorphine—Abdominal pain—Epirubicin—thyroid cancer	0.000141	0.000667	CcSEcCtD
Buprenorphine—Body temperature increased—Epirubicin—thyroid cancer	0.000141	0.000667	CcSEcCtD
Buprenorphine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000136	0.000644	CcSEcCtD
Buprenorphine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000135	0.000639	CcSEcCtD
Buprenorphine—Hypersensitivity—Epirubicin—thyroid cancer	0.000131	0.000622	CcSEcCtD
Buprenorphine—Urticaria—Doxorubicin—thyroid cancer	0.000131	0.000621	CcSEcCtD
Buprenorphine—Abdominal pain—Doxorubicin—thyroid cancer	0.00013	0.000618	CcSEcCtD
Buprenorphine—Body temperature increased—Doxorubicin—thyroid cancer	0.00013	0.000618	CcSEcCtD
Buprenorphine—Asthenia—Epirubicin—thyroid cancer	0.000128	0.000606	CcSEcCtD
Buprenorphine—Pruritus—Epirubicin—thyroid cancer	0.000126	0.000597	CcSEcCtD
Buprenorphine—Diarrhoea—Epirubicin—thyroid cancer	0.000122	0.000578	CcSEcCtD
Buprenorphine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000121	0.000576	CcSEcCtD
Buprenorphine—Asthenia—Doxorubicin—thyroid cancer	0.000118	0.00056	CcSEcCtD
Buprenorphine—Dizziness—Epirubicin—thyroid cancer	0.000118	0.000558	CcSEcCtD
Buprenorphine—Pruritus—Doxorubicin—thyroid cancer	0.000117	0.000553	CcSEcCtD
Buprenorphine—Vomiting—Epirubicin—thyroid cancer	0.000113	0.000537	CcSEcCtD
Buprenorphine—Diarrhoea—Doxorubicin—thyroid cancer	0.000113	0.000535	CcSEcCtD
Buprenorphine—Rash—Epirubicin—thyroid cancer	0.000112	0.000532	CcSEcCtD
Buprenorphine—Dermatitis—Epirubicin—thyroid cancer	0.000112	0.000532	CcSEcCtD
Buprenorphine—Headache—Epirubicin—thyroid cancer	0.000112	0.000529	CcSEcCtD
Buprenorphine—Dizziness—Doxorubicin—thyroid cancer	0.000109	0.000517	CcSEcCtD
Buprenorphine—Nausea—Epirubicin—thyroid cancer	0.000106	0.000501	CcSEcCtD
Buprenorphine—Vomiting—Doxorubicin—thyroid cancer	0.000105	0.000497	CcSEcCtD
Buprenorphine—Rash—Doxorubicin—thyroid cancer	0.000104	0.000493	CcSEcCtD
Buprenorphine—Dermatitis—Doxorubicin—thyroid cancer	0.000104	0.000492	CcSEcCtD
Buprenorphine—Headache—Doxorubicin—thyroid cancer	0.000103	0.000489	CcSEcCtD
Buprenorphine—Nausea—Doxorubicin—thyroid cancer	9.78e-05	0.000464	CcSEcCtD
Buprenorphine—OPRM1—Signaling by GPCR—PTCH1—thyroid cancer	4.48e-05	0.000928	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—MINPP1—thyroid cancer	4.45e-05	0.000921	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—MINPP1—thyroid cancer	4.41e-05	0.000913	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CALCA—thyroid cancer	4.35e-05	0.0009	CbGpPWpGaD
Buprenorphine—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.34e-05	0.000899	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CHST14—thyroid cancer	4.33e-05	0.000897	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TCF7L1—thyroid cancer	4.26e-05	0.000881	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CDK1—thyroid cancer	4.23e-05	0.000875	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TSHR—thyroid cancer	4.2e-05	0.00087	CbGpPWpGaD
Buprenorphine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	4.17e-05	0.000862	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PRKAR1A—thyroid cancer	4.13e-05	0.000856	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	4.11e-05	0.000851	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—SST—thyroid cancer	4.1e-05	0.000849	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—NRAS—thyroid cancer	4.05e-05	0.000839	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—HPGD—thyroid cancer	4.03e-05	0.000835	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.01e-05	0.000831	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	3.96e-05	0.00082	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MEN1—thyroid cancer	3.95e-05	0.000818	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CALCA—thyroid cancer	3.95e-05	0.000817	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CHST14—thyroid cancer	3.87e-05	0.000801	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—TPR—thyroid cancer	3.81e-05	0.000789	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—BRAF—thyroid cancer	3.81e-05	0.000788	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—NDUFA13—thyroid cancer	3.78e-05	0.000783	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CHST14—thyroid cancer	3.77e-05	0.000781	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—MINPP1—thyroid cancer	3.77e-05	0.00078	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—NDUFA13—thyroid cancer	3.75e-05	0.000776	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PRKAR1A—thyroid cancer	3.75e-05	0.000776	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.73e-05	0.000772	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	3.73e-05	0.000772	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TSHR—thyroid cancer	3.69e-05	0.000763	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.67e-05	0.00076	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PRKAR1A—thyroid cancer	3.63e-05	0.000751	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—SLC5A5—thyroid cancer	3.61e-05	0.000747	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTCH1—thyroid cancer	3.57e-05	0.00074	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CDK1—thyroid cancer	3.57e-05	0.00074	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CHST14—thyroid cancer	3.56e-05	0.000736	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CHST14—thyroid cancer	3.53e-05	0.00073	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—HPGD—thyroid cancer	3.49e-05	0.000723	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—KRAS—thyroid cancer	3.49e-05	0.000722	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MEN1—thyroid cancer	3.46e-05	0.000717	CbGpPWpGaD
Buprenorphine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	3.45e-05	0.000715	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.4e-05	0.000703	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SST—thyroid cancer	3.27e-05	0.000677	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—TPR—thyroid cancer	3.23e-05	0.000669	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—NDUFA13—thyroid cancer	3.2e-05	0.000663	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—TPR—thyroid cancer	3.2e-05	0.000663	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.18e-05	0.000658	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	3.15e-05	0.000652	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CALCA—thyroid cancer	3.15e-05	0.000651	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	3.13e-05	0.000649	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—HPGD—thyroid cancer	3.12e-05	0.000645	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TSHR—thyroid cancer	3.11e-05	0.000645	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PRKAR1A—thyroid cancer	3.06e-05	0.000634	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—HPGD—thyroid cancer	3.04e-05	0.00063	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—RXRA—thyroid cancer	3.03e-05	0.000627	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CHST14—thyroid cancer	3.01e-05	0.000624	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—HRAS—thyroid cancer	2.96e-05	0.000614	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—TPR—thyroid cancer	2.94e-05	0.000608	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.94e-05	0.000608	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MEN1—thyroid cancer	2.93e-05	0.000606	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.91e-05	0.000602	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	2.89e-05	0.000598	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—AKT1—thyroid cancer	2.88e-05	0.000597	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—HPGD—thyroid cancer	2.87e-05	0.000594	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SST—thyroid cancer	2.87e-05	0.000593	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—SLC5A5—thyroid cancer	2.85e-05	0.00059	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CDK1—thyroid cancer	2.85e-05	0.00059	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—HPGD—thyroid cancer	2.84e-05	0.000588	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.83e-05	0.000586	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.79e-05	0.000578	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CCND1—thyroid cancer	2.78e-05	0.000575	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CALCA—thyroid cancer	2.76e-05	0.000571	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—PTEN—thyroid cancer	2.68e-05	0.000555	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.67e-05	0.000553	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.65e-05	0.000549	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTCH1—thyroid cancer	2.65e-05	0.000548	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—AKT1—thyroid cancer	2.62e-05	0.000542	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.56e-05	0.00053	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.53e-05	0.000523	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CDK1—thyroid cancer	2.5e-05	0.000517	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.47e-05	0.000512	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—HPGD—thyroid cancer	2.43e-05	0.000503	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SST—thyroid cancer	2.42e-05	0.000501	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.42e-05	0.000501	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	2.4e-05	0.000496	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—RXRA—thyroid cancer	2.4e-05	0.000496	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—NRAS—thyroid cancer	2.39e-05	0.000495	CbGpPWpGaD
Buprenorphine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.35e-05	0.000486	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CALCA—thyroid cancer	2.33e-05	0.000483	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.33e-05	0.000482	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CHST14—thyroid cancer	2.33e-05	0.000481	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—TPR—thyroid cancer	2.32e-05	0.000479	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.31e-05	0.000477	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NRG1—thyroid cancer	2.29e-05	0.000473	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.28e-05	0.000472	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—SLC5A5—thyroid cancer	2.2e-05	0.000455	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CDK1—thyroid cancer	2.11e-05	0.000437	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—KRAS—thyroid cancer	2.06e-05	0.000426	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TERT—thyroid cancer	2.05e-05	0.000425	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—RXRA—thyroid cancer	2.03e-05	0.000421	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—RXRA—thyroid cancer	2.01e-05	0.000417	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—TPR—thyroid cancer	2.01e-05	0.000415	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NRG1—thyroid cancer	2e-05	0.000415	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.97e-05	0.000409	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.97e-05	0.000408	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.97e-05	0.000407	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HIF1A—thyroid cancer	1.96e-05	0.000406	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PPARG—thyroid cancer	1.91e-05	0.000396	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—HPGD—thyroid cancer	1.87e-05	0.000388	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—RXRA—thyroid cancer	1.85e-05	0.000382	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—TP53—thyroid cancer	1.83e-05	0.000379	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TERT—thyroid cancer	1.8e-05	0.000373	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—TPR—thyroid cancer	1.79e-05	0.000371	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.79e-05	0.00037	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.76e-05	0.000365	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—HRAS—thyroid cancer	1.75e-05	0.000362	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—TPR—thyroid cancer	1.75e-05	0.000362	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.75e-05	0.000362	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.73e-05	0.000359	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—NRAS—thyroid cancer	1.73e-05	0.000358	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	1.72e-05	0.000356	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.72e-05	0.000356	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NRG1—thyroid cancer	1.69e-05	0.000351	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—TPR—thyroid cancer	1.65e-05	0.000341	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—TPR—thyroid cancer	1.63e-05	0.000338	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—BRAF—thyroid cancer	1.63e-05	0.000337	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.62e-05	0.000335	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.61e-05	0.000332	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.6e-05	0.00033	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—AKT1—thyroid cancer	1.55e-05	0.00032	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TERT—thyroid cancer	1.52e-05	0.000315	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	1.52e-05	0.000314	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PPARG—thyroid cancer	1.51e-05	0.000313	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTGS2—thyroid cancer	1.51e-05	0.000312	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.5e-05	0.000311	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—KRAS—thyroid cancer	1.49e-05	0.000308	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.48e-05	0.000305	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—RXRA—thyroid cancer	1.46e-05	0.000302	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.46e-05	0.000301	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HIF1A—thyroid cancer	1.45e-05	0.000301	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—BRAF—thyroid cancer	1.43e-05	0.000295	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.41e-05	0.000291	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—TPR—thyroid cancer	1.39e-05	0.000289	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.37e-05	0.000284	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.34e-05	0.000277	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—PTEN—thyroid cancer	1.31e-05	0.000272	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.31e-05	0.000271	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	1.31e-05	0.00027	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PPARG—thyroid cancer	1.28e-05	0.000266	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—NRAS—thyroid cancer	1.28e-05	0.000265	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PPARG—thyroid cancer	1.27e-05	0.000263	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—HRAS—thyroid cancer	1.27e-05	0.000262	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—RXRA—thyroid cancer	1.26e-05	0.000261	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.26e-05	0.00026	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.24e-05	0.000258	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.23e-05	0.000255	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—AKT1—thyroid cancer	1.23e-05	0.000255	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.23e-05	0.000254	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.22e-05	0.000253	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—BRAF—thyroid cancer	1.2e-05	0.000249	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTGS2—thyroid cancer	1.19e-05	0.000246	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCND1—thyroid cancer	1.19e-05	0.000246	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PPARG—thyroid cancer	1.17e-05	0.000241	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.15e-05	0.000237	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—PTEN—thyroid cancer	1.14e-05	0.000237	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—RXRA—thyroid cancer	1.13e-05	0.000233	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—AKT1—thyroid cancer	1.12e-05	0.000231	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	1.11e-05	0.00023	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—KRAS—thyroid cancer	1.1e-05	0.000228	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—RXRA—thyroid cancer	1.1e-05	0.000228	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.1e-05	0.000227	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	1.08e-05	0.000223	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—TPR—thyroid cancer	1.08e-05	0.000223	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.06e-05	0.000219	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.04e-05	0.000216	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCND1—thyroid cancer	1.04e-05	0.000215	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—PTEN—thyroid cancer	1.04e-05	0.000215	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—RXRA—thyroid cancer	1.04e-05	0.000214	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—RXRA—thyroid cancer	1.03e-05	0.000213	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—NRAS—thyroid cancer	1.02e-05	0.000211	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTGS2—thyroid cancer	1.01e-05	0.000209	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—PTEN—thyroid cancer	1e-05	0.000208	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTGS2—thyroid cancer	1e-05	0.000207	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.99e-06	0.000207	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	9.79e-06	0.000203	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.78e-06	0.000203	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—HRAS—thyroid cancer	9.37e-06	0.000194	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PPARG—thyroid cancer	9.2e-06	0.00019	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTGS2—thyroid cancer	9.17e-06	0.00019	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—AKT1—thyroid cancer	9.12e-06	0.000189	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—NRAS—thyroid cancer	8.96e-06	0.000185	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—PTEN—thyroid cancer	8.8e-06	0.000182	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—KRAS—thyroid cancer	8.79e-06	0.000182	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCND1—thyroid cancer	8.79e-06	0.000182	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—RXRA—thyroid cancer	8.77e-06	0.000182	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—PTEN—thyroid cancer	8.73e-06	0.000181	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.53e-06	0.000177	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—PTEN—thyroid cancer	8.49e-06	0.000176	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—AKT1—thyroid cancer	8.28e-06	0.000171	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	8.06e-06	0.000167	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—PTEN—thyroid cancer	8e-06	0.000166	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PPARG—thyroid cancer	7.96e-06	0.000165	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—TP53—thyroid cancer	7.81e-06	0.000162	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—KRAS—thyroid cancer	7.71e-06	0.00016	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—NRAS—thyroid cancer	7.57e-06	0.000157	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—AKT1—thyroid cancer	7.57e-06	0.000157	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—HRAS—thyroid cancer	7.47e-06	0.000155	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTGS2—thyroid cancer	7.23e-06	0.00015	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PPARG—thyroid cancer	7.11e-06	0.000147	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PPARG—thyroid cancer	6.94e-06	0.000144	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—TP53—thyroid cancer	6.85e-06	0.000142	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—RXRA—thyroid cancer	6.77e-06	0.00014	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—AKT1—thyroid cancer	6.6e-06	0.000137	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—HRAS—thyroid cancer	6.55e-06	0.000136	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PPARG—thyroid cancer	6.54e-06	0.000135	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—KRAS—thyroid cancer	6.52e-06	0.000135	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PPARG—thyroid cancer	6.48e-06	0.000134	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—PTEN—thyroid cancer	6.31e-06	0.000131	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTGS2—thyroid cancer	6.27e-06	0.00013	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—AKT1—thyroid cancer	5.98e-06	0.000124	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—TP53—thyroid cancer	5.79e-06	0.00012	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—AKT1—thyroid cancer	5.79e-06	0.00012	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.59e-06	0.000116	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PPARG—thyroid cancer	5.54e-06	0.000115	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—HRAS—thyroid cancer	5.54e-06	0.000115	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—PTEN—thyroid cancer	5.46e-06	0.000113	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTGS2—thyroid cancer	5.46e-06	0.000113	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTGS2—thyroid cancer	5.14e-06	0.000106	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.1e-06	0.000106	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—AKT1—thyroid cancer	5.07e-06	0.000105	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—AKT1—thyroid cancer	5.03e-06	0.000104	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—AKT1—thyroid cancer	4.89e-06	0.000101	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—PTEN—thyroid cancer	4.88e-06	0.000101	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—PTEN—thyroid cancer	4.76e-06	9.86e-05	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—AKT1—thyroid cancer	4.61e-06	9.54e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—PTEN—thyroid cancer	4.49e-06	9.29e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—PTEN—thyroid cancer	4.45e-06	9.21e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTGS2—thyroid cancer	4.36e-06	9.02e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PPARG—thyroid cancer	4.28e-06	8.85e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—PTEN—thyroid cancer	3.8e-06	7.87e-05	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—AKT1—thyroid cancer	3.64e-06	7.53e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.36e-06	6.96e-05	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—AKT1—thyroid cancer	3.15e-06	6.52e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—PTEN—thyroid cancer	2.93e-06	6.07e-05	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—AKT1—thyroid cancer	2.81e-06	5.82e-05	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—AKT1—thyroid cancer	2.74e-06	5.68e-05	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—AKT1—thyroid cancer	2.59e-06	5.35e-05	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—AKT1—thyroid cancer	2.56e-06	5.31e-05	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—AKT1—thyroid cancer	2.19e-06	4.53e-05	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—AKT1—thyroid cancer	1.69e-06	3.5e-05	CbGpPWpGaD
